Proteomic profiling of paclitaxel treated cells identifies a novel mechanism of drug resistance mediated by PDCD4

Journal of Proteome Research

Volumn 14, Issue 6, 2015, Pages 2480-2491

  Xu, Hui ^a   Dephoure, Noah ^b   Sun, Huiying ^a   Zhang, Haiyuan ^a   Fan, Fangfang ^a   Liu, Jiawei ^a   Ning, Xuelian ^a   Dai, Shaochun ^a   Liu, Baogang ^a   Gao, Min ^a   Fu, Songbin ^a   Gygi, Steven P ^b   Zhou, Chunshui ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cell cycle; drug sensitivity; lung cancer; paclitaxel; PDCD4; personalized chemotherapy; quantitative proteomics; UBE2S

Indexed keywords

CELL PROTEIN; MESSENGER RNA; PACLITAXEL; PDCD4 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UBE2S PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; PDCD4 PROTEIN, HUMAN; PROTEIN BINDING; RNA BINDING PROTEIN;

ADJUVANT THERAPY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RESISTANCE; CANCER SURVIVAL; CANCER TISSUE; CELL ADHESION; CELL CYCLE PROGRESSION; CELL VIABILITY ASSAY; CHEMOSENSITIVITY; CHINESE; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXTRACELLULAR SPACE; GENE SILENCING; GLOBAL CHANGE; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; LUNG CANCER; MEIOTIC SPINDLE; MOLECULAR MECHANICS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN RNA BINDING; PROTEOMICS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SURVIVAL TIME; CHINA; DATABASE MANAGEMENT SYSTEM; DRUG RESISTANCE; LUNG TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; SURVIVAL ANALYSIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; CHINA; DATABASE MANAGEMENT SYSTEMS; DRUG RESISTANCE, NEOPLASM; HUMANS; LUNG NEOPLASMS; PACLITAXEL; PROTEIN BINDING; PROTEOMICS; RNA-BINDING PROTEINS; SURVIVAL ANALYSIS;

EID: 84930586812     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/acs.jproteome.5b00004     Document Type: Article

References (50)

1. Schiff, P. B.; Fant, J.; Horwitz, S. B. Promotion of microtubule assembly in vitro by taxol Nature 1979, 277 (5698) 665-7
2. Jordan, M. A.; Wendell, K.; Gardiner, S.; Derry, W. B.; Copp, H.; Wilson, L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death Cancer Res. 1996, 56 (4) 816-25
3. Gascoigne, K. E.; Taylor, S. S. How do anti-mitotic drugs kill cancer cells? J. Cell Sci. 2009, 122 (Pt 15) 2579-85
4. Rieder, C. L.; Maiato, H. Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint Dev Cell 2004, 7 (5) 637-51
5. Rowinsky, E. K.; Eisenhauer, E. A.; Chaudhry, V.; Arbuck, S. G.; Donehower, R. C. Clinical toxicities encountered with paclitaxel (Taxol) Semin. Oncol. 1993, 20 (4 Suppl 3) 1-15
6. Giannakakou, P.; Sackett, D. L.; Kang, Y. K.; Zhan, Z.; Buters, J. T.; Fojo, T.; Poruchynsky, M. S. Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization J. Biol. Chem. 1997, 272 (27) 17118-25
7. Yin, S.; Zeng, C.; Hari, M.; Cabral, F. Paclitaxel resistance by random mutagenesis of alpha-tubulin Cytoskeleton 2013, 70 (12) 849-62
8. Januchowski, R.; Wojtowicz, K.; Andrzejewska, M.; Zabel, M. Expression of MDR1 and MDR3 gene products in paclitaxel-, doxorubicin- and vincristine-resistant cell lines Biomed. Pharmacother. 2013, 68 (1) 111-7
9. Kavallaris, M.; Annereau, J. P.; Barret, J. M. Potential mechanisms of resistance to microtubule inhibitors Semin. Oncol. 2008, 35 (3 Suppl 3) S22-7
10. Murphy, L.; Henry, M.; Meleady, P.; Clynes, M.; Keenan, J. Proteomic investigation of taxol and taxotere resistance and invasiveness in a squamous lung carcinoma cell line Biochim. Biophys. Acta 2008, 1784 (9) 1184-91
11. Shibahara, K.; Asano, M.; Ishida, Y.; Aoki, T.; Koike, T.; Honjo, T. Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death Gene 1995, 166 (2) 297-301
12. Cmarik, J. L.; Min, H.; Hegamyer, G.; Zhan, S.; Kulesz-Martin, M.; Yoshinaga, H.; Matsuhashi, S.; Colburn, N. H. Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation Proc. Natl. Acad. Sci. U.S.A. 1999, 96 (24) 14037-42
13. Jansen, A. P.; Camalier, C. E.; Colburn, N. H. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis Cancer Res. 2005, 65 (14) 6034-41
14. Chen, Y.; Knosel, T.; Kristiansen, G.; Pietas, A.; Garber, M. E.; Matsuhashi, S.; Ozaki, I.; Petersen, I. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis J. Pathol. 2003, 200 (5) 640-6
15. Mudduluru, G.; Medved, F.; Grobholz, R.; Jost, C.; Gruber, A.; Leupold, J. H.; Post, S.; Jansen, A.; Colburn, N. H.; Allgayer, H. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer Cancer 2007, 110 (8) 1697-707
16. Wang, Q.; Sun, Z.; Yang, H. S. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells Oncogene 2008, 27 (11) 1527-35
17. Zhang, H.; Ozaki, I.; Mizuta, T.; Hamajima, H.; Yasutake, T.; Eguchi, Y.; Ideguchi, H.; Yamamoto, K.; Matsuhashi, S. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma Oncogene 2006, 25 (45) 6101-12
18. Niu, J.; Shi, Y.; Tan, G.; Yang, C. H.; Fan, M.; Pfeffer, L. M.; Wu, Z. H. DNA damage induces NF-kappaB-dependent microRNA-21 up-regulation and promotes breast cancer cell invasion J. Biol. Chem. 2012, 287 (26) 21783-95
19. Asangani, I. A.; Rasheed, S. A.; Nikolova, D. A.; Leupold, J. H.; Colburn, N. H.; Post, S.; Allgayer, H. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and stimulates invasion, intravasation and metastasis in colorectal cancer Oncogene 2008, 27 (15) 2128-36
20. Frankel, L. B.; Christoffersen, N. R.; Jacobsen, A.; Lindow, M.; Krogh, A.; Lund, A. H. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells J. Biol. Chem. 2008, 283 (2) 1026-33
21. Dorrello, N. V.; Peschiaroli, A.; Guardavaccaro, D.; Colburn, N. H.; Sherman, N. E.; Pagano, M. S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth Science 2006, 314 (5798) 467-71
22. Schmid, T.; Jansen, A. P.; Baker, A. R.; Hegamyer, G.; Hagan, J. P.; Colburn, N. H. Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion Cancer Res. 2008, 68 (5) 1254-60
23. Jansen, A. P.; Camalier, C. E.; Stark, C.; Colburn, N. H. Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity Mol. Cancer Ther. 2004, 3 (2) 103-10
24. Ong, S. E.; Blagoev, B.; Kratchmarova, I.; Kristensen, D. B.; Steen, H.; Pandey, A.; Mann, M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics Mol. Cell. Proteomics 2002, 1 (5) 376-86
25. Rappsilber, J.; Ishihama, Y.; Mann, M. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics Anal. Chem. 2003, 75 (3) 663-70
26. Bakalarski, C. E.; Elias, J. E.; Villen, J.; Haas, W.; Gerber, S. A.; Everley, P. A.; Gygi, S. P. The impact of peptide abundance and dynamic range on stable-isotope-based quantitative proteomic analyses J. Proteome Res. 2008, 7 (11) 4756-65
27. Murakami, H.; Ito, S.; Tanaka, H.; Kondo, E.; Kodera, Y.; Nakanishi, H. Establishment of new intraperitoneal paclitaxel-resistant gastric cancer cell lines and comprehensive gene expression analysis Anticancer Res. 2013, 33 (10) 4299-307
28. Ahn, K. C.; Choi, J. Y.; Kim, J. S.; Hwang, S. G.; Kim, W. J.; Park, J. K.; Um, H. D. ICAM-3 endows anticancer drug resistance against microtubule-damaging agents via activation of the ICAM-3-AKT/ERK-CREB-2 pathway and blockage of apoptosis Biochem. Biophys. Res. Commun. 2013, 441 (2) 507-13
29. Wu, T.; Merbl, Y.; Huo, Y.; Gallop, J. L.; Tzur, A.; Kirschner, M. W. UBE2S drives elongation of K11-linked ubiquitin chains by the anaphase-promoting complex Proc. Natl. Acad. Sci. U.S.A. 2009, 107 (4) 1355-60
30. Tedesco, D.; Zhang, J.; Trinh, L.; Lalehzadeh, G.; Meisner, R.; Yamaguchi, K. D.; Ruderman, D. L.; Dinter, H.; Zajchowski, D. A. The ubiquitin-conjugating enzyme E2-EPF is overexpressed in primary breast cancer and modulates sensitivity to topoisomerase II inhibition Neoplasia 2007, 9 (7) 601-13
31. Warmoes, M.; Jaspers, J. E.; Xu, G.; Sampadi, B. K.; Pham, T. V.; Knol, J. C.; Piersma, S. R.; Boven, E.; Jonkers, J.; Rottenberg, S.; Jimenez, C. R. Proteomics of genetically engineered mouse mammary tumors identifies fatty acid metabolism members as potential predictive markers for cisplatin resistance Mol. Cell. Proteomics 2013, 12 (5) 1319-34
32. Prins, J. M.; Wang, Y. Quantitative proteomic analysis revealed N′-nitrosonornicotine-induced down-regulation of nonmuscle myosin II and reduced cell migration in cultured human skin fibroblast cells J. Proteome Res. 2013, 12 (3) 1282-8
33. Kumar, A.; Baycin-Hizal, D.; Shiloach, J.; Bowen, M. A.; Betenbaugh, M. J. Coupling enrichment methods with proteomics for understanding and treating disease Proteomics Clin. Appl. 2015, 9 (1-2) 33-47
34. Sun, L.; Chen, L.; Sun, L.; Pan, J.; Yu, L.; Han, L.; Yang, Z.; Luo, Y.; Ran, Y. Functional screen for secreted proteins by monoclonal antibody library and identification of Mac-2 Binding protein (Mac-2BP) as a potential therapeutic target and biomarker for lung cancer Mol. Cell. Proteomics 2013, 12 (2) 395-406
35. Wang, X.; Zhang, A.; Wang, P.; Sun, H.; Wu, G.; Sun, W.; Lv, H.; Jiao, G.; Xu, H.; Yuan, Y.; Liu, L.; Zou, D.; Wu, Z.; Han, Y.; Yan, G.; Dong, W.; Wu, F.; Dong, T.; Yu, Y.; Zhang, S.; Wu, X.; Tong, X.; Meng, X. Metabolomics coupled with proteomics advancing drug discovery toward more agile development of targeted combination therapies Mol. Cell. Proteomics 2013, 12 (5) 1226-38
36. Zhang, F.; Fu, L.; Wang, Y. 6-thioguanine induces mitochondrial dysfunction and oxidative DNA damage in acute lymphoblastic leukemia cells Mol. Cell. Proteomics 2013, 12 (12) 3803-11
37. Lu, P.; Sun, H.; Zhang, L.; Hou, H.; Zhang, L.; Zhao, F.; Ge, C.; Yao, M.; Wang, T.; Li, J. Isocorydine targets the drug-resistant cellular side population through PDCD4-related apoptosis in hepatocellular carcinoma Mol. Med. 2012, 18, 1136-46
38. Merline, R.; Moreth, K.; Beckmann, J.; Nastase, M. V.; Zeng-Brouwers, J.; Tralhao, J. G.; Lemarchand, P.; Pfeilschifter, J.; Schaefer, R. M.; Iozzo, R. V.; Schaefer, L. Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21 Sci. Signaling 2011, 4 (199) ra75
39. Kroczynska, B.; Sharma, B.; Eklund, E. A.; Fish, E. N.; Platanias, L. C. Regulatory effects of programmed cell death 4 (PDCD4) protein in interferon (IFN)-stimulated gene expression and generation of type I IFN responses Mol. Cell. Biol. 2012, 32 (14) 2809-22
40. Olsen, J. V.; Vermeulen, M.; Santamaria, A.; Kumar, C.; Miller, M. L.; Jensen, L. J.; Gnad, F.; Cox, J.; Jensen, T. S.; Nigg, E. A.; Brunak, S.; Mann, M. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis Sci. Signaling 2010, 3 (104) ra3
41. Sultan, A.; K, T.; Chan, J.; Wang, Y.; Duran, G.; Francisco, B.; Sikic, B. Significance of MicroRNAs in determining taxane resistance in ovarian cancer Gynecol. Oncol. 2012, 125 (Suppl 1) S131
42. Chan, J. K.; Blansit, K.; Kiet, T.; Sherman, A.; Wong, G.; Earle, C.; Bourguignon, L. Y. The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer Gynecol. Oncol. 2014, 132 (3) 739-44
43. Shi, G. H.; Ye, D. W.; Yao, X. D.; Zhang, S. L.; Dai, B.; Zhang, H. L.; Shen, Y. J.; Zhu, Y.; Zhu, Y. P.; Xiao, W. J.; Ma, C. G. Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells Acta Pharmacol. Sin. 2010, 31 (7) 867-73
44. Ren, Y.; Zhou, X.; Mei, M.; Yuan, X. B.; Han, L.; Wang, G. X.; Jia, Z. F.; Xu, P.; Pu, P. Y.; Kang, C. S. MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol BMC Cancer 2010, 10, 27
45. Wedeken, L.; Singh, P.; Klempnauer, K. H. Tumor suppressor protein Pdcd4 inhibits translation of p53 mRNA J. Biol. Chem. 2011, 286 (50) 42855-62
46. Singh, P.; Wedeken, L.; Waters, L. C.; Carr, M. D.; Klempnauer, K. H. PDCD4 directly binds the coding region of c-myb mRNA and suppresses its translation Oncogene 2011, 30 (49) 4864-73
47. Liwak, U.; Thakor, N.; Jordan, L. E.; Roy, R.; Lewis, S. M.; Pardo, O. E.; Seckl, M.; Holcik, M. Tumor suppressor PDCD4 represses internal ribosome entry site-mediated translation of antiapoptotic proteins and is regulated by S6 kinase 2 Mol. Cell. Biol. 2012, 32 (10) 1818-29
48. Meric-Bernstam, F.; Chen, H.; Akcakanat, A.; Do, K. A.; Lluch, A.; Hennessy, B. T.; Hortobagyi, G. N.; Mills, G. B.; Gonzalez-Angulo, A. M. Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer Breast Cancer Res. 2012, 14 (5) R138
49. Garnett, M. J.; Mansfeld, J.; Godwin, C.; Matsusaka, T.; Wu, J.; Russell, P.; Pines, J.; Venkitaraman, A. R. UBE2S elongates ubiquitin chains on APC/C substrates to promote mitotic exit Nat. Cell Biol. 2009, 11 (11) 1363-9
50. Warner, S. L.; S, B.; Nwokenkwo, S.; Hostetter, G.; Sugeng, A.; Hidalgo, M.; Trent, J. M.; Han, H.; Von Hoff, D. D. Validation of TPX2 as a Potential Therapeutic Target in Pancreatic Cancer Cells Clin. Cancer Res. 2009, 15, 6519-28